Cargando…
Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44]
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mosby
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184954/ https://www.ncbi.nlm.nih.gov/pubmed/31839177 http://dx.doi.org/10.1016/j.ahj.2019.11.008 |
| _version_ | 1783526672391208960 |
|---|---|
| author | Loeb, Mark Dokainish, Hisham Dans, Antonio Palileo-Villanueva, Lia M Roy, Ambuj Karaye, Kamilu Zhu, Jun Liang, Yan Goma, Fastone Damasceno, Albertino AlHabib, Khalid F Yonga, Gerald Mondo, Charles Almahmeed, Wael Al Mulla, Arif Yusuf, Salim |
| author_facet | Loeb, Mark Dokainish, Hisham Dans, Antonio Palileo-Villanueva, Lia M Roy, Ambuj Karaye, Kamilu Zhu, Jun Liang, Yan Goma, Fastone Damasceno, Albertino AlHabib, Khalid F Yonga, Gerald Mondo, Charles Almahmeed, Wael Al Mulla, Arif Yusuf, Salim |
| author_sort | Loeb, Mark |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7184954 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Mosby |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71849542020-04-28 Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44] Loeb, Mark Dokainish, Hisham Dans, Antonio Palileo-Villanueva, Lia M Roy, Ambuj Karaye, Kamilu Zhu, Jun Liang, Yan Goma, Fastone Damasceno, Albertino AlHabib, Khalid F Yonga, Gerald Mondo, Charles Almahmeed, Wael Al Mulla, Arif Yusuf, Salim Am Heart J Article Mosby 2020-03 /pmc/articles/PMC7184954/ /pubmed/31839177 http://dx.doi.org/10.1016/j.ahj.2019.11.008 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Article Loeb, Mark Dokainish, Hisham Dans, Antonio Palileo-Villanueva, Lia M Roy, Ambuj Karaye, Kamilu Zhu, Jun Liang, Yan Goma, Fastone Damasceno, Albertino AlHabib, Khalid F Yonga, Gerald Mondo, Charles Almahmeed, Wael Al Mulla, Arif Yusuf, Salim Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44] |
| title | Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44] |
| title_full | Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44] |
| title_fullStr | Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44] |
| title_full_unstemmed | Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44] |
| title_short | Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44] |
| title_sort | corrigendum to “randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (ivve): rationale and design” [212 (2019) 36–44] |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184954/ https://www.ncbi.nlm.nih.gov/pubmed/31839177 http://dx.doi.org/10.1016/j.ahj.2019.11.008 |
| work_keys_str_mv | AT loebmark corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT dokainishhisham corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT dansantonio corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT palileovillanuevaliam corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT royambuj corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT karayekamilu corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT zhujun corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT liangyan corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT gomafastone corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT damascenoalbertino corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT alhabibkhalidf corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT yongagerald corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT mondocharles corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT almahmeedwael corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT almullaarif corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT yusufsalim corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 AT corrigendumtorandomizedcontrolledtrialofinfluenzavaccineinpatientswithheartfailuretoreduceadversevasculareventsivverationaleanddesign21220193644 |